Hot Pursuit     27-Oct-23
Shalby jumps after Q2 PAT rises 50% YoY
Shalby spurted 8.21% to Rs 261.50 after the company announced that its consolidated net profit rose 49.8% to Rs 27.58 crore on 17.9% increase in net sales to Rs 237.98 crore in Q2 September 2023 over Q2 September 2022.
Profit before tax stood at Rs 42.63 crore in the Q2FY24, up 48.6% YoY and down 29.3% QoQ.

During the quarter, the company's revenue from healthcare services segment rose 25.62% YoY to Rs 223.33 crore while its revenue from its business of manufacturing implants fell 39% YoY to Rs 14.64 crore. The healthcare services segment includes business of setting up and managing hospitals and medical diagnostics services.

Total expenses rose 12.5% to Rs 185.26 crore in Q2 FY24 over Q2 FY23. During the quarter, operative expense stood at Rs 110.05 crore (down 16% YoY) while employee benefits expense was at Rs 38.56 crore (up 14.5% YoY).

Net cash flow from operating activities stood at Rs 95.14 crore as on 30 September 2023, lower than Rs 141.97 crore as on 31 March 2023.

Shalby is the largest chain of multi-specialty hospitals in Western and Central India. It was founded by arthroplasty specialist, Dr. Vikram Shah. It performs more than 14,000 joint replacement surgeries a year and in the last 29 years has performed more than 1,45,000 joint replacements. It operates under three main verticals, namely, hospital business, Shalby Orthopedics Centre of Excellence (SOCE) franchise and implant business.

Previous News
  Shalby standalone net profit rises 60.37% in the June 2018 quarter
 ( Results - Announcements 14-Aug-18   12:46 )
  Shalby consolidated net profit rises 70.62% in the September 2022 quarter
 ( Results - Announcements 19-Oct-22   08:31 )
  Board of Shalby appoints director
 ( Corporate News - 19-Oct-22   09:30 )
  Shalby launches state-of-the-art radiotherapy centre
 ( Corporate News - 06-Feb-18   19:13 )
  Shalby schedules board meeting
 ( Corporate News - 11-Oct-22   12:07 )
  Board of Shalby to consider reducing promoter holding to 75%
 ( Corporate News - 24-Sep-20   09:40 )
  Shalby
 ( Results - Analysis 29-May-24   09:36 )
  Shalby consolidated net profit declines 0.45% in the June 2022 quarter
 ( Results - Announcements 26-Jul-22   14:55 )
  Shalby's subsidiary to invest in Shalby Global Technologies, Singapore
 ( Corporate News - 18-Dec-23   15:14 )
  Shalby gains after Singapore arm bags import license for orthopaedic products
 ( Hot Pursuit - 16-Feb-23   11:23 )
  Shalby to discuss results
 ( Corporate News - 09-Jun-20   17:40 )
Other Stories
  SBI Life Insurance Company Ltd gains for third straight session
  05-Jul-24   13:05
  Marico Ltd soars 1.27%, Gains for third straight session
  05-Jul-24   13:05
  L&T Technology Services Ltd up for third straight session
  05-Jul-24   13:05
  Vedanta Ltd soars 1.36%, rises for third straight session
  05-Jul-24   13:05
  Hindustan Zinc Ltd soars 1.2%, Gains for third straight session
  05-Jul-24   13:05
  Hindustan Copper Ltd spurts 1.15%, up for third straight session
  05-Jul-24   13:05
  Glenmark Pharmaceuticals Ltd spurts 3.8%, rises for third straight session
  05-Jul-24   13:05
  Granules India Ltd soars 2.74%, Gains for third straight session
  05-Jul-24   13:05
  Alkem Laboratories Ltd soars 1.34%, rises for third straight session
  05-Jul-24   13:05
  Ipca Laboratories Ltd up for third straight session
  05-Jul-24   13:05
Back Top